Immune-mediated ophthalmoparesis with anti-GD1a antibodies

BMJ Case Rep. 2021 Nov 18;14(11):e244273. doi: 10.1136/bcr-2021-244273.

Abstract

A young woman presented to neurology with a 1 month history of progressive diplopia on lateral gaze and a 1 week history of headaches. On examination she was found to have complex ophthalmoparesis with binocular horizontal diplopia, failure of abduction bilaterally and limited upgaze with convergence-retraction nystagmus. The rest of the neurological examination was normal. She was admitted for investigations: blood, CT brain, MR brain and lumbar puncture results were normal. Anti-GD1a antibodies were strongly positive; anti-GM1, anti-GM2 and anti-GD1b were also positive. On follow-up 3 weeks later, the complex ophthalmoplegia persisted. It was decided to treat with intravenous immunoglobulins (IVIgs) with good response but recurrence at 2 weeks post infusion. She was treated with 4 weekly IVIg courses and remains responsive and controlled over 1 year since presentation but becomes symptomatic in the week running up to each dose; thus, disease modifying treatment is currently being considered.

Keywords: cranial nerves; neurology; neurology (drugs and medicines); neuroopthalmology.

Publication types

  • Case Reports

MeSH terms

  • Diplopia / etiology
  • Female
  • Gangliosides*
  • Headache
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Ophthalmoplegia* / diagnosis
  • Ophthalmoplegia* / drug therapy

Substances

  • Gangliosides
  • Immunoglobulins, Intravenous